American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
Emslie GJ, Kennard BD, Kowatch RA. Affective disorders in children: diagnosis and management. J Child Neurol.1995;10(suppl):42-49.
Birmaher B, Ryan ND, Williamson DE.
et al. Childhood and adolescent depression: a review of the past 10 years,
part 1. J Am Acad Child Adolesc Psychiatry.1996;35:1427-1439.
Kovacs M. Presentation and course of major depressive disorder during childhood
and later years of the life span. J Am Acad Child Adolesc Psychiatry.1996;35:705-715.
McCauley E, Myers K, Mitchell J, Calderon R, Schloredt K, Treder R. Depression in young people: initial presentation and clinical course. J Am Acad Child Adolesc Psychiatry.1993;32:714-722.
Birmaher B, Brent DA, Benson RS. Summary of the practice parameters for the assessment and treatment
of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry.1998;37:1234-1238.
Kovacs M, Feinberg TL, Crouse-Novak M, Paulauskas SL, Pollock M, Finkelstein R. Depressive disorders in childhood, I: a longitudinal prospective study
of characteristics and recovery. Arch Gen Psychiatry.1984;41:229-237.
Lewinsohn PM, Clarke GN, Seeley JR, Rohde P. Major depression in community adolescents: age at onset, episode duration,
and time to recurrence. J Am Acad Child Adolesc Psychiatry.1994;33:809-818.
Kovacs M, Feinberg TL, Crouse-Novak M, Paulauskas SL, Pollack M, Finkelstein R. Depressive disorders in childhood, II: a longitudinal study of the
risk for a subsequent major depression. Arch Gen Psychiatry.1984;41:643-649.
Klerman GL, Weissman MM. Increasing rates of depression. JAMA.1989;261:2229-2235.
Gershon ES, Hamovit JH, Guroff JJ, Nurnberger JI. Birth-cohort changes in manic and depressive disorders in relatives
of bipolar and schioaffective patients. Arch Gen Psychiatry.1987;44:314-319.
Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression
and minor depression among adolescents and young adults in the National Comorbidity
Survey. Depress Anxiety.1998;7:3-14.
Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national comorbidity
sample: the National Comorbidity Survey. Am J Psychiatry.1994;151:979-986.
Weissman MM, Wolk S, Wickramaratne P.
et al. Children with prepubertal-onset major depressive disorder and anxiety
grown up. Arch Gen Psychiatry.1999;56:794-801.
Weissman MM, Wolk S, Goldstein RB.
et al. Depressed adolescents grown up. JAMA.1999;281:1707-1713.
Pine DS, Cohen P, Gurley D, Brook J, Ma Y. The risk for early-adulthood anxiety and depressive disorders in adolescents
with anxiety and depressive disorders. Arch Gen Psychiatry.1998;55:56-64.
Berndt ER, Koran LM, Finkelstein SN.
et al. Lost human capital from early-onset chronic depression. Am J Psychiatry.2000;157:940-947.
Rao U, Weissman MM, Martin JA, Hammond RW. Childhood depression and risk of suicide: a preliminary report of a
longitudinal study. J Am Acad Child Adolesc Psychiatry.1993;32:21-27.
Ornstein S, Stuart G, Jenkins R. Depression diagnoses and antidepressant use in primary care practices:
a study from the Practice Partner Research Network (PRPNet). J Fam Pract.2000;49:68-72.
Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression:
a meta-analysis. BMJ.1995;310:897-901.
Ambrosini PJ. A review of pharmacotherapy of major depression in children and adolescents. Psychiatr Serv.2000;51:627-633.
Kastelic EA, Labellarte MJ, Riddle MA. Selective serotonin reuptake inhibitors for children and adolescents. Curr Psychiatry Rep.2000;2:117-123.
Boulos C, Kutcher S, Gardner D, Young E. An open naturalistic trial of fluoxetine in adolescents and young adults
with treatment-resistant major depression. J Child Adolesc Psychopharmacol.1992;2:103-111.
Colle LM, Belair J-F, DiFeo M. Extended open-label treatment of adolescents with major depression. J Child Adolesc Psychopharmacol.1994;4:225-232.
Ghaziuddin N, Naylor MW, King CA. Fluoxetine in tricyclic refractory depression in adolescents. Depression.1995;2:287-291.
Findling R, Fiala S, Myers C. Putative determinants of paroxetine response in pediatric patients
with major depression [abstract]. Psychopharmacol Bull.1996;32:446.
Rey-Sanchez F, Gutierrez-Casares JR. Paroxetine in children with major depressive disorder: an open trial. J Am Acad Child Adolesc Psychiatry.1997;36:1443-1447.
Apter A, Ratzoni G, King RA.
et al. Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive
disorder or depression. J Am Acad Child Adolesc Psychiatry.1994;33:342-348.
Emslie GJ, Rush J, Weinberg WA.
et al. A double-blind, randomized, placebo-controlled trial of fluoxetine
in children and adolescents with depression. Arch Gen Psychiatry.1997;54:1031-1037.
Emslie GJ, Heiligenstein JH, Wagner KD.
et al. Fluoxetine for acute treatment of depression in children and adolescents:
a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry.2002;41:1205-1215.
Keller MB, Ryan ND, Strober M.
et al. Efficacy of paroxetine in the treatment of adolescent major depression:
a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry.2001;40:762-772.
McConville BJ, Minnery KL, Sorter MT, West SA, Friedman LM, Christian K. An open study of the effects of sertraline on adolescent depression. J Child Adolesc Psychopharmacol.1996;6:41-51.
Ambrosini PJ, Wagner KD, Biederman J.
et al. Multicenter open-label sertraline study in adolescent outpatients with
major depression. J Am Acad Child Adolesc Psychiatry.1999;38:566-572.
Nixon MK, Milin R, Simeon JG, Cloutier P, Spenst W. Sertraline effects in adolescent major depression and dysthymia: a
six-month open trial. J Child Adolesc Psychopharmacol.2001;11:131-142.
Tierney E, Joshi PT, Llinas JF, Rosenberg LA, Riddle MA. Sertraline for major depression in children and adolescents: preliminary
clinical experience. J Child Adolesc Psychopharmacol.1995;5:13-27.
Kaufman J, Birmaher B, Brent D.
et al. Schedule for affective disorders and schizophrenia for school-age children—present
and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry.1997;36:980-988.
Poznanski EO, Freeman LN, Mokros HB. Children's Depression Rating Scale—Revised (September 1984). Psychopharmacol Bull.1985;21:979-989.
Poznanski EO, Mokros HB. Children's Depression Rating Scale, Revised (CDRS-R)
Manual. Los Angeles, Calif: Western Psychological Services; 1995.
Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, Md: National Institute of Mental Health; 1976.
March JS, Parker JD, Sullivan K, Stallings P, Conners CK. The multidimensional anxiety scale for children (MASC): factor structure,
reliability, and validity. J Am Acad Child Adolesc Psychiatry.1997;36:554-565.
Schaffer D, Gould MS, Brasic J.
et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry.1983;40:1228-1231.
Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull.1993;29:321-326.
Findling R, Reed M, Blumer J. Pharmacological treatment of depression in children and adolescents. Paediatr Drugs.1999;1:161-182.
Amsterdam J, Brunswick D. Site variability in treatment outcome in antidepressant trials. Prog Neuropsychopharmacol Biol Psychiatry.2002;26:989-993.
Small G, Schneider, L, Hamilton S.
et al. Site variability in a multisite geriatric depression trial. Int J Geriatr Psychiatry.1996;11:1089-1095.
Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression. JAMA.2002;287:1840-1847.
FDA Discusses Pediatric Drug Safety With its Advisory
Subcommittee Under Best Pharmaceuticals for Children Act . Washington, DC: US Food and Drug Administration; 2003. FDA Talk Paper
Alderman J, Wolkow R, Chung M, Johnston HF. Sertraline treatment of children and adolescents with obsessive-compulsive
disorder or depression: pharmacokinetics, tolerability, and efficacy. J Am Acad Child Adolesc Psychiatry.1998;37:386-394.
Rynn M, Wagner KD, Donnelly C, Ambrosini PJ, Landau P, Wohlberg C. Long-term safety and tolerability of sertraline in children and adolescents
with MDD. Paper presented at: 156th Annual Meeting of the American Psychiatric
Association; May 17-22, 2003; San Francisco, Calif.